Enveric Biosciences Subsidiary Jay Pharma Receives Decision To Grant European Patent Titled ‘COMPOSITIONS COMPRISING CANNABIDIOL AND SECOND THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER’
https://register.epo.org/application?number=EP16801851